Trials / Completed
CompletedNCT07103629
Bringing Knowledge About Chronic Kidney Disease in Brazil: Filling the Gap
Cross-sectional Study to Evaluate the Chronic Kidney Disease Prevalence Using a Creatinine Point-of-care Tool in Brazilian Adult Patients With Known CKD Risk Factors Randomly Selected
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8,428 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a multicenter cross-sectional study will randomly screen kidney function in adult patients with known risk factors for chronic kidney disease (CKD) within the Brazilian general population. Kidney function will be assessed using a point-of-care creatinine test at local healthcare facilities. Patients with abnormal test results will be referred for laboratory confirmation within three months and will undergo evaluation by the local nephrology team to determine the need for follow-up care.
Conditions
Timeline
- Start date
- 2025-05-31
- Primary completion
- 2025-09-30
- Completion
- 2025-09-30
- First posted
- 2025-08-05
- Last updated
- 2025-10-08
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT07103629. Inclusion in this directory is not an endorsement.